Sparian Biosciences
Harnessing the diversity of gene processing
Sparian Biosciences is a bio-pharmaceutical company focusing on discovering and developing new therapies which target the central nervous system (CNS).
About
Sparian Biosciences is a bio-pharmaceutical company focusing on discovering and developing new therapies which target the central nervous system (CNS).
The treatment of CNS diseases, such as pain, addiction and psychological disorders, has seen no true pharmaceutical innovation in years.
Sparian was co-founded by Gavril Pasternak, MD PhD and Jeff Reich, MD after the Pasternak Lab discovered a novel new analgesic (e.g. pain killer) with better pain relief than morphine while minimizing the adverse side effects that cause other opioids.
Through groundbreaking research, innovative thinking and expert collaboration, our company feels we could change the way CNS diseases are treated on a global scale.
To learn more, click below
Our Team
Pipeline
Arylepoxamides
Arylepoxamides are a new class of drugs which have been found to bind the newly discovered AEAr receptors.
Precision Neuropsychiatry
Make this yours. Add images, text and links, or connect data from your collection.
Mitragynine Derivatives
Make this yours. Add images, text and links, or connect data from your collection.